Newegg Commerce, Inc. sees a brief stock rally post-reverse split but faces weak Q4 results and uncertain FY25 outlook. Click ...

Micron's fundamentals are strengthening, driven by aggressive R&D and AI momentum. Click here to see why MU stock is a Buy.

Aalborg University's recent study challenges the notion of segregated communities in Denmark, revealing that ethnic integration is progressing fa ...

While not often thought of as the pack leader on food regulatory issues, West Virginia recently did just that by becoming the ...

His case changed when KNH invited him to join the TSR surgical camp between April 28 and May 2, offering him a chance to ...

Scientists are using ancient DNA and gene editing to bring back woolly mammoths—possibly by 2028. This controversial project ...

In the basement of 55 Church St. sits one of just three NeuroExplorer PET scanners in the world. Capable of producing images with significantly better resolution and sensitivity than its 20-year-old ...

Top business executives and industry experts convened Tuesday at the 2025 US Strategy Roundtable for Pharma and Biotech to assess Korea’s biotech standing at a critical juncture of global ...

China’s WuXi AppTec, which a US legislative commission called the “Huawei equivalent for biotechnology”, has reported a surge in US business despite increased scrutiny from Washington ...

The Food and Drug Administration is projecting a more favorable stance toward biotech, emphasizing streamlined processes and accelerated approvals (“FDA Sends a Bullish Signal to Biotech ...

Biotech firm Jade Biosciences Inc. has completed its merger with Aerovate Therapeutics Inc. (Nasdaq:AVTE), in a move that will put the former on the Nasdaq. Jade’s Vancouver-based CEO, Tom ...

German drug company Merck KGaA said Monday it has struck a deal to buy U.S. biotech firm SpringWorks Therapeutics for around $3.9 billion, expanding its portfolio of rare disease and cancer ...